0001209191-23-007318.txt : 20230206 0001209191-23-007318.hdr.sgml : 20230206 20230206164809 ACCESSION NUMBER: 0001209191-23-007318 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230202 FILED AS OF DATE: 20230206 DATE AS OF CHANGE: 20230206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cahill Brian Joseph CENTRAL INDEX KEY: 0001831591 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36306 FILM NUMBER: 23591286 MAIL ADDRESS: STREET 1: C/O EAGLE PHARMACEUTICALS, INC. STREET 2: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000827871 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-326-5300 MAIL ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19880120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-02 0 0000827871 EAGLE PHARMACEUTICALS, INC. EGRX 0001831591 Cahill Brian Joseph C/O EAGLE PHARMACEUTICALS, INC. 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 0 1 0 0 Chief Financial Officer Common Stock 2023-02-02 4 F 0 785 34.09 D 30086 D The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units. /s/ Brian Cahill 2023-02-06